Drug Approval | November 20, 2024
Lupin receives USFDA approval for mixed salts of a single-entity amphetamine ER capsules
The product will be manufactured at Lupin’s Somerset facility in the US
The product will be manufactured at Lupin’s Somerset facility in the US
Recommendation based on LAURA Phase III trial results which showed Tagrisso extended median progression-free survival to more than three years
Aromatic L-amino acid decarboxylase deficiency is a rare genetic disorder that affects the production of some neurotransmitters
Opinion granted based on positive overall survival results from the IND.227/KEYNOTE-483 trial
Emraclidine was well-tolerated with an adverse event profile consistent with Phase 1b trial
Net profit for the quarter grew by 254.2 per cent and stood at Rs. 20.9 crore
This product will be manufactured at Lupin’s Nagpur facility in India
The Pediatric vaccine portfolio delivered double-digit growth and maintained its market leadership in the private market
Revolf's infertility and miscarriage tests are a new technology that uses blood tests to detect neoself-antibodies
Data demonstrate the importance of protecting against serious respiratory infections caused by respiratory syncytial virus, human metapneumovirus and COVID-19
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
